Nu Skin Stock Sinks After Weak Quarter, Soft Outlook
Nu Skin Enterprises Inc. (NYSE:NUS) reported fourth-quarter 2025 results on Thursday after market close and provided a 2026 outlook. The stock declined following the announcement.
The company missed analyst expectations, reporting GAAP diluted EPS of 29 cents compared to a 30-cent estimate, and revenue of $370.32 million versus an expected $382.70 million.
Revenue declined 16.9% from $445.55 million a year ago. EPS, excluding restructuring and other charges, was 29 cents compared to 38 cents last year.
Gross margin increased to 70.7% from 62.7%. Operating margin improved to 6.3% from a negative 11.9%. The customer base totaled 748,796, down 10%. Paid affiliates numbered 129,311, a decrease of 11%, and sales leaders totaled 30,045, down 19%.
The company said more than 20,000 Prysm iO devices are already in the hands of its sales leaders, generating more than 700,000 scans. It has begun pre-market activities in India ahead of a full market opening anticipated in the back half of the year.
By segment, Nu Skin revenue was $321.80 million, down from $362.45 million. Rhyz’s revenue was $48.52 million, down from $83.10 million.
Nu Skin ended 2025 with $238.63 million in cash and cash equivalents. Total debt was $224.19 million, of which $20.0 million was due within one year.
Ryan Napierski, Nu Skin president and CEO, commented, “This past year was a pivotal year as we furthered our transformation toward becoming the world’s leading intelligent beauty and wellness platform and laid the groundwork for our 2026 growth initiatives.”
“Looking ahead, we continue to build sales leader alignment in the first half of the year around the global launch of Prysm iO, positioning us for a return to year-over-year revenue growth by year’s end.”
Outlook
For the first quarter of 2026, Nu Skin forecasts revenue between $320.00 million and $340.00 million, below the $356.80 million estimate. The company expects GAAP EPS of 10 to 20 cents, compared to a 27-cent estimate.
For full-year 2026, the company projects revenue between $1.35 billion and $1.50 billion, compared to a $1.53 billion estimate. GAAP EPS is expected to range from 80 cents to $1.20, versus a $1.42 estimate.
NUS Price Action: Nu Skin Enterprises shares were down 16.75% at $8.50 during premarket trading on Friday.
Image via Shutterstock
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Swiss Franc struggles as SNB dovish stance lifts USD/CHF
SUI SuperTrend Buy Signal Flashes — Last Time It Appeared, SUI Rallied 77.53%
Has the return on Amazon's massive AI capital expenditure been underestimated by the market?
Amazon is trading at 29 times expected earnings, lower than Walmart’s 37 times, even though its revenue growth rate is three times that of Walmart. This inversion reflects deep market concerns over whether AI capital expenditures will deliver as anticipated. AWS CEO Matt Garman revealed that AWS’s annual revenue has reached $160–170 billion, with a growth rate of 37%. Enterprise cloud migration, AI-native startups, and intelligent agent workflows are simultaneously driving three growth curves.
TSMC’s $2 Billion Silicon Interposer Order Given to GlobalFoundries, Key CoWoS Components to be Produced in the U.S. for the First Time
This move marks the official extension of a key link in the AI packaging supply chain to the United States. Analysis indicates that the five-year long-term contract reflects TSMC's strong long-term outlook for silicon interposer demand. Meanwhile, Taiwanese companies UMC and PSMC are actively expanding capacity to compete for orders, but this major order has been secured by GlobalFoundries, meaning that American production capacity will become a new factor in the silicon interposer market landscape over the next five years.
Crypto prices
More
